ConductScience.org, home

Paper19200044

Trypanothione reductase from Leishmania infantum: cloning, expression, purification, crystallization and preliminary X-ray data analysis.

Baiocco P and 3 others. Protein Pept Lett, 2009. Cited by 37 papers, by iCite.

Cite this record

ConductScience Library. Trypanothione reductase from Leishmania infantum: cloning, expression, purification, crystallization and preliminary X-ray data analysis. Papers, record 19200044. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19200044

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Trypanothione reductase from Leishmania infantum: cloning, expression, purification, crystallization and preliminary X-ray data analysis.
PubMed
Journal
Protein Pept Lett
PubMed
Year
2009
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
1.2
iCite
Revised in PubMed
2019-09-11
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Baiocco PPaola
2Franceschini SStefano
3Ilari AAndrea
4Colotti GGianni

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Leishmania infantumMajor topic
NADH, NADPH OxidoreductasesMajor topic
Animals
Cloning, Molecular
Crystallography, X-Ray
Electrophoresis, Polyacrylamide Gel
Escherichia coli
Recombinant Proteins
Spectrophotometry, Ultraviolet

Source PubMed

Download CSV of topics

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
42758390Antileishmanial activity of gold(I) compounds containing triphenylphosphine ligands against Leishmania amazonensis: impacts on mitochondrial bioenergetics and trypanothione reductase activity.Biometals2026https://conductscience.org/library/papers/42758390PubMed
41701359Molecular docking: a computational approach for the discovery of novel targets against visceral leishmaniasis.J Mol Model2026https://conductscience.org/library/papers/41701359PubMed
39088331Deciphering Host-Parasite Interplay in Leishmania Infection through a One Health View of Proteomics Studies on Drug Resistance.ACS Infect Dis2024https://conductscience.org/library/papers/39088331PubMed
38003236In Silico Exploration of the Trypanothione Reductase (TryR) of L. mexicana.Int J Mol Sci2023https://conductscience.org/library/papers/38003236PubMed
36615531Inhibition of Leishmania infantum Trypanothione Reductase by New Aminopropanone Derivatives Interacting with the NADPH Binding Site.Molecules2023https://conductscience.org/library/papers/36615531PubMed
34181199Druggable hot spots in trypanothione reductase: novel insights and opportunities for drug discovery revealed by DRUGpy.J Comput Aided Mol Des2021https://conductscience.org/library/papers/34181199PubMed
33945281Efficient Dimerization Disruption of Leishmania infantum Trypanothione Reductase by Triazole-phenyl-thiazoles.J Med Chem2021https://conductscience.org/library/papers/33945281PubMed
33842389Epigallocathechin-O-3-Gallate Inhibits Trypanothione Reductase of Leishmania infantum, Causing Alterations in Redox Balance and Leading to Parasite Death.Front Cell Infect Microbiol2021https://conductscience.org/library/papers/33842389PubMed
32437349Spiro-containing derivatives show antiparasitic activity against Trypanosoma brucei through inhibition of the trypanothione reductase enzyme.PLoS Negl Trop Dis2020https://conductscience.org/library/papers/32437349PubMed
31131262Immunomodulation From Moderate Exercise Promotes Control of Experimental Cutaneous Leishmaniasis.Front Cell Infect Microbiol2019https://conductscience.org/library/papers/31131262PubMed
30475811Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening.PLoS Negl Trop Dis2018https://conductscience.org/library/papers/30475811PubMed
29077741RNA-seq transcriptional profiling of Leishmania amazonensis reveals an arginase-dependent gene expression regulation.PLoS Negl Trop Dis2017https://conductscience.org/library/papers/29077741PubMed
28098499Inhibition of Leishmania infantum trypanothione reductase by diaryl sulfide derivatives.J Enzyme Inhib Med Chem2017https://conductscience.org/library/papers/28098499PubMed
21833767
A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition.
Amino Acids2012https://conductscience.org/library/papers/21833767PubMed
21717278Evaluation of plumbagin and its derivative as potential modulators of redox thiol metabolism of Leishmania parasite.Parasitol Res2012https://conductscience.org/library/papers/21717278PubMed
21359528Evaluation of selected antitumor agents as subversive substrate and potential inhibitor of trypanothione reductase: an alternative approach for chemotherapy of Leishmaniasis.Mol Cell Biochem2011https://conductscience.org/library/papers/21359528PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19200044

GET https://conductscience.org/api/papers/v1/19200044/authors